Charles Ryhee
Stock Analyst at TD Cowen
(2.42)
# 2,487
Out of 5,115 analysts
17
Total ratings
60%
Success rate
10.88%
Average return
Main Sectors:
Stocks Rated by Charles Ryhee
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CVS CVS Health | Maintains: Buy | $73 → $80 | $74.52 | +7.35% | 5 | Nov 25, 2024 | |
| MCK McKesson | Maintains: Buy | $563 → $652 | $831.21 | -21.56% | 4 | May 8, 2024 | |
| CVX Chevron | Maintains: Outperform | $185 → $170 | $176.90 | -3.90% | 3 | Feb 24, 2023 | |
| EVH Evolent Health | Maintains: Outperform | $57 → $59 | $3.21 | +1,738.01% | 2 | Jan 30, 2023 | |
| CAH Cardinal Health | Maintains: Market Perform | $59 → $72 | $214.88 | -66.49% | 1 | Aug 16, 2022 | |
| TDOC Teladoc Health | Maintains: Outperform | $240 → $188 | $5.45 | +3,349.54% | 1 | Aug 9, 2021 | |
| OSCR Oscar Health | Initiates: Market Perform | $29 | $14.35 | +102.09% | 1 | Mar 29, 2021 |
CVS Health
Nov 25, 2024
Maintains: Buy
Price Target: $73 → $80
Current: $74.52
Upside: +7.35%
McKesson
May 8, 2024
Maintains: Buy
Price Target: $563 → $652
Current: $831.21
Upside: -21.56%
Chevron
Feb 24, 2023
Maintains: Outperform
Price Target: $185 → $170
Current: $176.90
Upside: -3.90%
Evolent Health
Jan 30, 2023
Maintains: Outperform
Price Target: $57 → $59
Current: $3.21
Upside: +1,738.01%
Cardinal Health
Aug 16, 2022
Maintains: Market Perform
Price Target: $59 → $72
Current: $214.88
Upside: -66.49%
Teladoc Health
Aug 9, 2021
Maintains: Outperform
Price Target: $240 → $188
Current: $5.45
Upside: +3,349.54%
Oscar Health
Mar 29, 2021
Initiates: Market Perform
Price Target: $29
Current: $14.35
Upside: +102.09%